1. Home
  2. HBIO vs VCIG Comparison

HBIO vs VCIG Comparison

Compare HBIO & VCIG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HBIO
  • VCIG
  • Stock Information
  • Founded
  • HBIO 1901
  • VCIG 2013
  • Country
  • HBIO United States
  • VCIG Malaysia
  • Employees
  • HBIO N/A
  • VCIG 58
  • Industry
  • HBIO Biotechnology: Laboratory Analytical Instruments
  • VCIG Diversified Commercial Services
  • Sector
  • HBIO Industrials
  • VCIG Consumer Discretionary
  • Exchange
  • HBIO Nasdaq
  • VCIG Nasdaq
  • Market Cap
  • HBIO 24.6M
  • VCIG 7.5M
  • IPO Year
  • HBIO 2000
  • VCIG 2023
  • Fundamental
  • Price
  • HBIO $0.52
  • VCIG $1.10
  • Analyst Decision
  • HBIO Buy
  • VCIG
  • Analyst Count
  • HBIO 3
  • VCIG 0
  • Target Price
  • HBIO $2.50
  • VCIG N/A
  • AVG Volume (30 Days)
  • HBIO 18.1M
  • VCIG 4.7M
  • Earning Date
  • HBIO 11-06-2025
  • VCIG 10-06-2025
  • Dividend Yield
  • HBIO N/A
  • VCIG N/A
  • EPS Growth
  • HBIO N/A
  • VCIG N/A
  • EPS
  • HBIO N/A
  • VCIG 5.34
  • Revenue
  • HBIO $88,750,000.00
  • VCIG $32,903,041.00
  • Revenue This Year
  • HBIO N/A
  • VCIG N/A
  • Revenue Next Year
  • HBIO $7.02
  • VCIG N/A
  • P/E Ratio
  • HBIO N/A
  • VCIG $0.21
  • Revenue Growth
  • HBIO N/A
  • VCIG 24.77
  • 52 Week Low
  • HBIO $0.28
  • VCIG $1.11
  • 52 Week High
  • HBIO $2.82
  • VCIG $4,644.00
  • Technical
  • Relative Strength Index (RSI)
  • HBIO 54.48
  • VCIG 27.29
  • Support Level
  • HBIO $0.48
  • VCIG $1.75
  • Resistance Level
  • HBIO $0.65
  • VCIG $3.54
  • Average True Range (ATR)
  • HBIO 0.08
  • VCIG 0.46
  • MACD
  • HBIO 0.02
  • VCIG -0.10
  • Stochastic Oscillator
  • HBIO 24.98
  • VCIG 2.40

About HBIO Harvard Bioscience Inc.

Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, pharmaceutical and therapy discovery, bioproduction, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, and Panlab. The majority of its revenue comes from the United States.

About VCIG VCI Global Limited

VCI Global Ltd is a holding company. The principal activities of the Company and its subsidiaries are the provision of business Strategy consultancy and technology development. The firm organized its consulting services into three main segments: Business Strategy Consultancy; Technology development, solutions and consultancy; and Others. It derives the majority of its revenue from the Business Strategy Consultancy segment, which focuses on listing solutions, investor relations, and boardroom strategies consultancy.

Share on Social Networks: